NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Masimo Corporation (MASI) Stock Analysis

Masimo Corporation (MASI) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

MASI

$179.95

$0.00 (0.00%)

Last trade June 12, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MASI with… →

MASI Key Statistics

As of Jun 12, 2026
Trading
Open
$179.95
Previous Close
$179.95
52-Week Range
125.94–179.00
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.13
Valuation
Market Cap
$9.36B
P/E Ratio
44.23
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
27.06
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.00
EPS (ttm)Profit attributable to each share over the last twelve months.
4.04
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
4.90%
1-Year Return
+8.84%
Dividend and dates
Avg Volume
1.21M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MASI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+38.36%
2025−21.32%
2024 (partial year)−2.76%

As of June 12, 2026.

MASI Valuation vs Medical Devices Median

Median of 151 stocks
MetricMASIMedical Devices medianvs median
P/E44.2326.8065% above
P/S ratio6.002.98102% above
Profit margin4.90%−1.69%6.6 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Masimo Corporation (MASI) is capitalised at $9.36B on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 2,200.

MASI last closed at $179.95 on June 12, 2026. The close was unchanged from the previous session. The 52-week range on file runs from $125.94 to $179.00. The latest close sits 42.89% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $1.56B. The reported profit margin is 4.9%. That is 6.6 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 4.04.

Valuation Assessment

MASI trades at a trailing price-to-earnings ratio of 44.23. That is 65.04% above the Medical Devices median of 26.8. On forward earnings the ratio is 27.06. Measured against sales, the shares trade at 6 times revenue. On price-to-sales that is 101.73% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is +8.84%. Beta against the wider market is reported at 1.13. Annualized volatility over the trailing 1 year is 45.13%.

Growth & Income

No dividend is on file for MASI.

2026 is still running; the price is +38.36% year to date. The record holds one complete calendar year, 2025, which returned −21.32%.

Peer Comparison

Masimo Corporation (MASI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Masimo Corporation MASI $9.36B 44.2
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Masimo Corporation trades at a P/E of 44.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of June 12, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Masimo Corporation

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Visit website →